Markets open on strong note; Sensex jumps 503 points
The Hindu
Benchmark indices rebounded with Asian markets, led by HDFC Bank and Reliance Industries; FIIs offloaded equities.
Benchmark equity indices rebounded in early trade on Monday in-tandem with a rally in Asian markets along with buying in blue chip firms HDFC Bank and Reliance Industries.
The 30-share BSE Sensex jumped 503.47 points to 71,204.14 points in the early trade. Nifty climbed 178.55 points to 21,531.15 points.
Among the Sensex firms, Sun Pharma, Axis Bank, Kotak Mahindra Bank, Power Grid, Larsen and Toubro, NTPC, ICICI Bank, HDFC Bank and Reliance Industries were the major gainers.
JSW Steel, Infosys, ITC and Mahindra And Mahindra were among the laggards.
In Asian markets, Seoul, Tokyo, Shanghai and Hong Kong were trading in the positive territory. The U.S. markets had ended on a mixed note on Friday.
Global oil benchmark Brent crude climbed 0.51% to $83.98 a barrel.
Markets were closed on Friday on account of Republic Day.
Gold and silver prices surge to record highs as investors seek safe havens amid geopolitical tensions and rate-cut expectations.
Stock markets decline after two days of gains, with subdued trading expected amid a holiday-shortened week.
Rupee dips to 89.73 against the dollar as Sensex and Nifty also decline amid FII outflows and weak market conditions.
Mercedes-Benz settles multistate emissions allegations for $149.6 million, addressing illegal devices in over 211,000 vehicles.
U.S. approves Wegovy pill for weight loss, expanding access to obesity treatment with a convenient daily oral option.
RBI Bulletin highlights resilient economic activity in India, driven by robust demand, despite challenges in external trade and inflation.
Biofabri and Bharat Biotech partner to advance MTBVAC, a tuberculosis vaccine, ensuring equitable access and manufacturing readiness in India.
India anticipates doubling trade with New Zealand to $5 billion in five years following a historic women-led free trade agreement.
Rupee dips 3 paise to 89.70 against the dollar amid trade deal concerns and rising crude oil prices.
Government to release new series of retail inflation, GDP data from February, IIP from May next year
The Indian government will release new macroeconomic data series, including GDP and inflation, starting February 2026.
Granules India secures U.S. FDA tentative approval for its ADHD generic, enhancing access to critical therapy and expanding its generics portfolio.
Italy’s competition authority (AGCM) said on Monday it had fined U.S technology giant Apple and two of its divisions 98.6 million euros ($115.53 million) over alleged abuse of their dominant position in the mobile app market.
India denies duty concessions on dairy imports from New Zealand in recent trade pact negotiations, prioritizing local farmers' protection.